Home Feedback Contents

HIV
Up Anaerobes Aspergillosis Botulism Candidiasis Cholera CMV infection Creutzfeldt Jakob Fever HIV Infection control Leptospirosis Line infection Malaria Meliodosis Meningococcal disease Microbiology Needle stick injury Neutropenic fever PIRO Rickettsia SDD Sepsis management Soft tissue Strongyloidiasis Toxic shock syndrome Tetanus Tuberculosis Viral diseases

Forthcoming BASIC courses: August - Brisbane, Hawkes Bay, Kuala Lumpur, Bali; September - Hong Kong; October - Sydney, Chennai
Click here for details


Immune reconstitution
Penicillium marneffei

Thomas Li & Charles Gomersall

Epidemiology

  • 40 million patients worldwide
  • 28.2 million in sub-Saharan Africa

Acquisition

  • sexual practices
  • needlestick injury
    • risk of transmission 1/300
  • vertical transmission
  • blood products
    • unusual with screening programs

Serious life threatening conditions

  • Pulmonary
    • Bacterial
      • Streptococcus pneumoniae

      • Haemophilus influenzae

      • Staphylococcus aureus

      • Klebsiella pneumoniae

      • Pseudomonas aeruginosa

      • Nocardia asteroides

    • Fungal
    • Mycobacterium
      • TB
      • Mycobacterium avium intracellulare (end-stage HIV disease)

    • Parasitic
      • Toxoplasma gondii

      • Strongyloides stercoralis

    • Viral
      • CMV
      • Influenza, parainfluenza, rhinovirus, adenovirus

  • CNS
    • Cryptococcus
    • Toxoplasma
  • Acute bacterial infections

Prognosis

  • ~70% of HIV +ve patients admitted to ICU are dead at 6 months
  • ICU mortality in HIV +ve patients without AIDS similar to HIV -ve patients
 

©Charles Gomersall, August, 2008 unless otherwise stated. The author, editor and The Chinese University of Hong Kong take no responsibility for any adverse event resulting from the use of this webpage.
Copyright policy    Contributors